FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3122822609> ?p ?o ?g. }

• W3122822609 abstract "Background: Abstract Background: The economic costs of depression are significant, both the direct medical costs of care and the indirect costs of lost productivity. Empirical studies of antidepressant cost-effectiveness suggest that the use of selective serotonin reuptake inhibitors (SSRI) may be no more costly than tricyclic antidepressants (TCA), will improve tolerability, and is associated with longer therapy duration. However the success of depression care usually involves multiple factors, including source of care, type of care, and patient characteristics, in addition to drug choice. The cost-effective mix of antidepressant therapy components is unclear.Aims of the Study: Our study evaluates cost and antidepressant-continuity outcomes for depressed patients receiving antidepressant therapy. Specifically, we determined the impact of provider choice for initial care, concurrent psychotherapy, and choice of SSRI versus TCA-based pharmacotherapies on the joint outcome of low treatment cost and continuous antidepressant therapy.Methods: A database of private health insurance claims identifies 2,678 patients who received both a diagnosis of depression and a prescription for an antidepressant during 1990-1994. Patients each fall into one of four groups according to whether their health care charges are high versus low (using the median value as the break point) and by whether their antidepressant usage pattern is continuous versus they discontinued pharmacotherapy early (filling fewer than six prescriptions). A bivariate probit model controlling for patient characteristics, co-morbidities, type of depression and concurrent treatment is the primary multivariate statistical vehicle for cost-effective treatment situation.Results: SSRIs substantially reduce the incidence of patients discontinuing pharmacotherapy while leaving charges largely unchanged. The relative effectiveness of SSRIs in depression treatment is independent of the patient’s personal characteristics and dominates the consequences of other treatment dimensions such as seeing a mental health specialist and receiving concurrent psychotherapy. Initial provider specialty is irrelevant to the continuity of pharmacotherapy, and concurrent psychotherapy creates a tradeoff through reduced pharmacotherapy interruption with higher costs.Discussion: Longer therapy duration is associated with SSRI-based pharmacotherapy (relative to TCA-based pharmacotherapy) and with concurrent psychotherapy. High cost is associated with concurrent psychotherapy and choice of a specialty provider for initial care. In our study cost-effective care includes SSRI-based pharmacotherapy initiated with a non-specialty provider. Previous treatment history and other unobserved factors that might affect antidepressant choice are not included in our model.Implications for Health Care Provision: The decision to use an SSRI-based pharmacotherapy need not consider carefully the patient’s personal characteristics. Shifting depressed patients’ pharmacotherapy away from TCAs to SSRIs has the effect of improving outcomes by lowering the incidence of discontinuation of pharmacotherapy while leaving largely unchanged the likelihood of having high overall health care charges. Targeted use of concurrent psychotherapy may be additionally cost-effective.Implications for Health Policies: The interaction of various components of depression care can alter the cost-effectiveness of antidepressant therapy. Our results demonstrate a role for the non-specialty provider in initiating care and support increased use of SSRIs as first-line therapy for depression as a way of providing cost-effective care that is consistent with APA guidelines for continuous antidepressant treatment.Implications for Further Research: Further research that improves our understanding of how decisions regarding provider choice, concurrent psychotherapy, and drug choice are made will improve our understanding of the effects treatment choices on the cost-effectiveness of depression care. We have suggested that targeted concurrent psychotherapy may prove to be cost-effective; research to determine groups most likely to benefit from the additional treatment would further enable clinicians and healthcare policy makers to form a consensus regarding a model for treating depression." @default.
• W3122822609 created "2021-02-01" @default.
• W3122822609 creator A5029455323 @default.
• W3122822609 creator A5050779662 @default.
• W3122822609 date "2000-12-01" @default.
• W3122822609 modified "2023-09-24" @default.
• W3122822609 title "Antidepressant Treatment for Depression: Total Charges and Therapy Duration" @default.
• W3122822609 hasPublicationYear "2000" @default.
• W3122822609 type Work @default.
• W3122822609 sameAs 3122822609 @default.
• W3122822609 citedByCount "1" @default.
• W3122822609 crossrefType "posted-content" @default.
• W3122822609 hasAuthorship W3122822609A5029455323 @default.
• W3122822609 hasAuthorship W3122822609A5050779662 @default.
• W3122822609 hasConcept C118552586 @default.
• W3122822609 hasConcept C126322002 @default.
• W3122822609 hasConcept C139719470 @default.
• W3122822609 hasConcept C162324750 @default.
• W3122822609 hasConcept C177713679 @default.
• W3122822609 hasConcept C197934379 @default.
• W3122822609 hasConcept C2426938 @default.
• W3122822609 hasConcept C2776867660 @default.
• W3122822609 hasConcept C2778375690 @default.
• W3122822609 hasConcept C2779177272 @default.
• W3122822609 hasConcept C2779657639 @default.
• W3122822609 hasConcept C500440147 @default.
• W3122822609 hasConcept C558461103 @default.
• W3122822609 hasConcept C71924100 @default.
• W3122822609 hasConcept C98274493 @default.
• W3122822609 hasConceptScore W3122822609C118552586 @default.
• W3122822609 hasConceptScore W3122822609C126322002 @default.
• W3122822609 hasConceptScore W3122822609C139719470 @default.
• W3122822609 hasConceptScore W3122822609C162324750 @default.
• W3122822609 hasConceptScore W3122822609C177713679 @default.
• W3122822609 hasConceptScore W3122822609C197934379 @default.
• W3122822609 hasConceptScore W3122822609C2426938 @default.
• W3122822609 hasConceptScore W3122822609C2776867660 @default.
• W3122822609 hasConceptScore W3122822609C2778375690 @default.
• W3122822609 hasConceptScore W3122822609C2779177272 @default.
• W3122822609 hasConceptScore W3122822609C2779657639 @default.
• W3122822609 hasConceptScore W3122822609C500440147 @default.
• W3122822609 hasConceptScore W3122822609C558461103 @default.
• W3122822609 hasConceptScore W3122822609C71924100 @default.
• W3122822609 hasConceptScore W3122822609C98274493 @default.
• W3122822609 hasLocation W31228226091 @default.
• W3122822609 hasOpenAccess W3122822609 @default.
• W3122822609 hasPrimaryLocation W31228226091 @default.
• W3122822609 hasRelatedWork W125975800 @default.
• W3122822609 hasRelatedWork W1564068429 @default.
• W3122822609 hasRelatedWork W181499380 @default.
• W3122822609 hasRelatedWork W1978048232 @default.
• W3122822609 hasRelatedWork W1978264463 @default.
• W3122822609 hasRelatedWork W2056142446 @default.
• W3122822609 hasRelatedWork W2079269107 @default.
• W3122822609 hasRelatedWork W2092807593 @default.
• W3122822609 hasRelatedWork W2096057259 @default.
• W3122822609 hasRelatedWork W2107183844 @default.
• W3122822609 hasRelatedWork W2109474313 @default.
• W3122822609 hasRelatedWork W2110404840 @default.
• W3122822609 hasRelatedWork W2227694644 @default.
• W3122822609 hasRelatedWork W2474589390 @default.
• W3122822609 hasRelatedWork W3024855628 @default.
• W3122822609 hasRelatedWork W3090794463 @default.
• W3122822609 hasRelatedWork W3122118338 @default.
• W3122822609 hasRelatedWork W3124143101 @default.
• W3122822609 hasRelatedWork W41819050 @default.
• W3122822609 hasRelatedWork W2525638139 @default.
• W3122822609 isParatext "false" @default.
• W3122822609 isRetracted "false" @default.
• W3122822609 magId "3122822609" @default.
• W3122822609 workType "article" @default.